ConvaTec Group PLC banner

ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 231 GBX -2.45% Market Closed
Market Cap: £4.5B

EV/OCF

15.8
Current
24%
Cheaper
vs 3-y average of 20.7

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
15.8
=
Enterprise Value
GBX5.4B
/
Operating Cash Flow
$470m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
15.8
=
Enterprise Value
GBX5.4B
/
Operating Cash Flow
$470m

Valuation Scenarios

ConvaTec Group PLC is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (20.7), the stock would be worth GBX303.17 (31% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-100%
Maximum Upside
+31%
Average Downside
35%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 15.8 GBX231
0%
3-Year Average 20.7 GBX303.17
+31%
5-Year Average 20.2 GBX295.6
+28%
Industry Average 0 GBX0.48
-100%
Country Average 0 GBX0.37
-100%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 15.8 34.2
US
Medline Inc
NASDAQ:MDLN
62.4B USD 0 0
JP
Hoya Corp
TSE:7741
9.8T JPY 36.7 39.1
CH
Alcon AG
SIX:ALC
30.5B CHF 18.1 38.9
DK
Coloplast A/S
CSE:COLO B
98.2B DKK 17.1 24.5
US
Align Technology Inc
NASDAQ:ALGN
13.9B USD 21.6 34
CA
Bausch + Lomb Corp
NYSE:BLCO
5.7B USD 36.5 -15.7
KR
HLB Inc
KOSDAQ:028300
8.3T KRW -89.5 -37.5
JP
Asahi Intecc Co Ltd
TSE:7747
895.2B JPY 20.9 50.6
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.3B USD 14.1 22.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
35.2B CNY 22.5 21.3
P/E Multiple
Earnings Growth PEG
UK
ConvaTec Group PLC
LSE:CTEC
Average P/E: 33.1
34.2
41%
0.8
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
39.1
15%
2.6
CH
Alcon AG
SIX:ALC
38.9
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.5
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
34
34%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.7 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -37.5 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.6
40%
1.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
22.6
30%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.3
9%
2.4

Market Distribution

Higher than 95% of companies in United Kingdom
Percentile
95th
Based on 1 947 companies
95th percentile
15.8
Low
0 — 0
Typical Range
0 — 0
High
0 —
Distribution Statistics
United Kingdom
Min 0
30th Percentile 0
Median 0
70th Percentile 0
Max 2 105.8

ConvaTec Group PLC
Glance View

Market Cap
4.5B GBX
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CTEC Intrinsic Value
200.95 GBX
Overvaluation 13%
Intrinsic Value
Price GBX231
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett